MARKET

NKTR

NKTR

Nektar
NASDAQ

Real-time Quotes | Nasdaq Last Sale

22.48
-1.42
-5.94%
After Hours: 22.40 -0.08 -0.36% 19:59 01/17 EST
OPEN
23.87
PREV CLOSE
23.90
HIGH
23.87
LOW
22.28
VOLUME
3.48M
TURNOVER
--
52 WEEK HIGH
47.11
52 WEEK LOW
15.64
MARKET CAP
3.95B
P/E (TTM)
-9.2090
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NKTR and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NKTR News

  • SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
  • GlobeNewswire.3d ago
  • Mid-Afternoon Market Update: OrganiGram Rises Following Q1 Results; Nektar Therapeutics Shares Plummet
  • Benzinga.4d ago
  • Mid-Day Market Update: Concrete Pumping Falls On Weak Q4 Results; Fluent Shares Jump
  • Benzinga.4d ago
  • How An FDA Committee Pulled The Rug Out From This Highflying Biotech
  • Investor's Business Daily.4d ago

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About NKTR

Nektar Therapeutics is a biopharmaceutical company that discovers and develops medicines in areas of high unmet medical need. The Company's research and development pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain. It leverages its chemistry platform to discover and design new drug candidates. These drug candidates utilize its polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action. Its programs include Immuno-oncology (I-O), Immunology, Pain-NKTR-181 and Oncology-ONZEALD. It is developing medicines designed to directly or indirectly modulate the activity of key immune cells, such as cytotoxic T cells and Natural Killer (NK) cells, to increase their numbers and improve their function to recognize and attack cancer cells.
More

Webull offers Nektar Therapeutics (NKTR) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.